Zeping Zhou

professor
The Second Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China (People's Republic)

Presentation(s):

• OC 21.5 - An Open-label,Dose-Escalation,Multicenter Phase I Study to Evaluate the Safety,Immunogenicity,and Pharmacokinetics/pharmacodynamics（PK/PD）of Single Dose SS109 in Hemophilia A/B patients with Inhibitor

  Sunday, June 23, 2024
  15:45 – 16:00 ICT

• PB0675 - Comparison of short-term efficacy, safety of glucocorticoids combined with different regimens of thrombopoietic agents in thetreatment of severe primary immune thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0705 - Functional changes of Belimumab on T cells in patients with ITP

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0686 - Functional changes of Blys and receptors in patients with ITP

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB1308 - Identification of a Novel ITGA2B Gene Mutation in a Child with Glanzmann's Thrombasthenia

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT